Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer [NA]
This clinical trial update reports ongoing recruitment for a study evaluating targeted biopsy plus sextant biopsy in the diagnosis of prosta…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency [Phase 2]
A Phase 2 trial evaluating a combination of docetaxel, carboplatin, and rucaparib camsylate in metastatic castration-resistant prostate canc…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations
The INSIDE study is identifying genomic screening pathways in cancer patients with DNA repair alterations and is currently recruiting for pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating [18]F-PSMA-1007 in patients with known or suspected metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation [Phase 2]
An ongoing Phase 2 clinical trial is recruiting to evaluate combining androgen deprivation therapy with focal prostate ablation in prostate …
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Synthetic Metabolic and Genetic Networks for Medical Diagnosics
This clinical trial update reports a terminated study from University Hospital, Montpellier investigating synthetic metabolic and genetic ne…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance [Phase 3]
A Phase 3 clinical trial investigating whether curcumin can prevent progression of low-risk prostate cancer in men under active surveillance…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
This update describes an ongoing advanced radiotherapy trial for prostate cancer (PROST-ART) that is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
This clinical trial update announces recruitment for a study aiming to identify biomarkers that predict how cancer patients respond to radia…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate [Phase 1]
Phase 1 trial evaluating pembrolizumab with chemotherapy for locally advanced or metastatic small cell and neuroendocrine cancers of the uro…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chitosan to pharmacologically manipulate AGE levels in prostate cancer was terminated; results were post…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours [Phase 3]
This entry describes the Add-Aspirin Phase 3 trial evaluating whether adding aspirin after primary therapy reduces recurrence and improves s…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) [Phase 1, Phase 2]
This Phase I/II trial of BN-Brachyury Vaccine, M7824, N-803, and Epacadostat in metastatic castration-resistant prostate cancer has complete…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Geriatric Assessment and Technology Evaluation in Prostate Cancer
A University of Chicago-initiated clinical trial evaluating geriatric assessment and technology in patients with prostate cancer, currently …
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: PET-MR-PSA Prostate Cancer Recidive Study
The PET-MR-PSA Prostate Cancer Recidive trial is currently active but not recruiting, focusing on imaging for recurrent prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Platelet Rich Plasma During Radical Prostatectomy [NA]
A Mayo Clinic trial evaluated using platelet-rich plasma during radical prostatectomy for prostate cancer; the study is completed and result…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Phase 3]
Phase 3 trial evaluating triptorelin in combination with radiation therapy after surgery for intermediate-risk stage III or stage IV prostat…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, National Survey, Aiming to Explore the Technics of Physiotherapy (PREduKiné)
A prospective, monocentric national survey (PREduKiné) evaluates physiotherapy techniques for postoperative rehabilitation after radical pro…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Marker Driven Selection of Patients for Prostate Biopsy and Management
Clinical trial update from the University of Miami describes a biomarker-driven approach to selecting men for prostate biopsy and managing e…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Novel Therapy Target in Metastatic Prostate Cancer
A clinical trial update describes a novel therapy target being studied for metastatic prostate cancer. The trial is currently recruiting at …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Curative Image Guided Radiotherapy for Prostate Cancer [NA]
The document provides an update on a clinical trial evaluating curative image-guided radiotherapy for prostate cancer, which is currently ac…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]
This is a Phase II multicohort trial assessing sEphB4-HSA in combination with pembrolizumab for solid tumors; the study is currently active …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating Hansoh's HS-10502 in adults with advanced solid tumors, including ovarian, breast, pancreatic, prostate, and colo…